Evidence map›Paper›PMID 35404981›Full record

ArticlePloS one2022

Effect of hypothyroidism on contractile performance of isolated end-stage failing human myocardium.

Nancy S Saad, Mohammed A Mashali, Mohammad T Elnakish, Austin Hare, Courtney M Campbell, Salome A Kiduko, Kyra K Peczkowski, Amanda W Huang, Farbod Fazlollahi, Gina S Torres Matias and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Thyrotoxic Cardiomyopathy: State of the Art.TouchREVIEWS in endocrinology · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Nancy S SaadDepartment of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.ORCID 0000-0002-5194-7515
Mohammed A MashaliDepartment of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.
Mohammad T ElnakishDepartment of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.
Austin HareDepartment of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.
Courtney M CampbellDepartment of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.ORCID 0000-0002-0803-0429
Salome A KidukoDepartment of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.
Kyra K PeczkowskiDepartment of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.
Amanda W HuangDepartment of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.ORCID 0000-0001-6393-5282
Farbod FazlollahiDepartment of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.ORCID 0000-0002-0954-5731
Gina S Torres MatiasDepartment of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.
Amany A E AhmedFaculty of Pharmacy, Department of Pharmacology and Toxicology, Helwan University, Cairo, Egypt.
Bryan A WhitsonDivision of Cardiac Surgery, College of Medicine, The Ohio State University, Columbus, OH, United States of America.
Nahush A MokadamDivision of Cardiac Surgery, College of Medicine, The Ohio State University, Columbus, OH, United States of America.
Paul M L JanssenDepartment of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.ORCID 0000-0002-9682-3014
Lung Institute · USThe Ohio State University · USDamanhour University · EGHelwan University · EG

Funding

Frequency-dependent modulation of cardiac myofilament function in health/diseaseR01HL113084 · NHLBI · OHIO STATE UNIVERSITY · PI JANSSEN, PAULUS ML · 2012 to 2023
$4.6M
NRSA Training CoreTL1TR002735 · NCATS · OHIO STATE UNIVERSITY · PI BUMGARDNER, GINNY L, KIRSCHNER, LAWRENCE S · 2018 to 2022
$1.3M
Electrical and mechanical behavior of live human myocardium in health and diseaseRC1HL099538 · NHLBI · OHIO STATE UNIVERSITY · PI JANSSEN, PAULUS ML · 2009 to 2010
$1.0M
NCATS NIH HHS TL1 TR002735NHLBI NIH HHS R01 HL113084NHLBI NIH HHS RC1 HL099538
6 · The paper itself

Abstract

The relationship between hypothyroidism and the occurrence and progression of heart failure (HF) has had increased interest over the past years. The low T3 syndrome, a reduced T3 in the presence of normal thyroid stimulating hormone (TSH), and free T4 concentration, is a strong predictor of all-cause mortality in HF patients. Still, the impact of hypothyroidism on the contractile properties of failing human myocardium is unknown. Our study aimed to investigate that impact using ex-vivo assessment of force and kinetics of contraction/relaxation in left ventricular intact human myocardial muscle preparations. Trabeculae were dissected from non-failing (NF; n = 9), failing with no hypothyroidism (FNH; n = 9), and failing with hypothyroidism (FH; n = 9) hearts. Isolated muscle preparations were transferred into a custom-made setup where baseline conditions as well as the three main physiological modulators that regulate the contractile strength, length-dependent and frequency-dependent activation, as well as β-adrenergic stimulation, were assessed under near-physiological conditions. Hypothyroidism did not show any additional significant impact on the contractile properties different from the recognized alterations usually detected in such parameters in any end-stage failing heart without thyroid dysfunction. Clinical information for FH patients in our study revealed they were all receiving levothyroxine. Absence of any difference between failing hearts with or without hypothyroidism, may possibly be due to the profound effects of the advanced stage of heart failure that concealed any changes between the groups. Still, we cannot exclude the possibility of differences that may have been present at earlier stages. The effects of THs supplementation such as levothyroxine on contractile force and kinetic parameters of failing human myocardium require further investigation to explore its full potential in improving cardiovascular performance and cardiovascular outcomes of HF associated with hypothyroidism.

Indexed as

Heart FailureHypothyroidismCalciumHumansMyocardial ContractionMyocardiumThyroxineCalciumThyroxine

Identifiers

PMID35404981
PMCPMC9000031
OpenAlexW4223651261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.